IDYA
IDEAYA Biosciences, Inc.
Next earnings Aug 3, 2026 · consensus $-1.09 EPS, $5.29M rev
Last earnings -0.3% on 2026-05-05
$36.95
▲ +5.83%$34.91▲ +59.26%
over 1Y
L $21.02EODHDH $37.86
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+5.8%
1W+14.2%
1M+18.9%
3M+14.3%
YTD+3.1%
1Y+59.3%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 25 analysts
Buy
Revenue grew 3024.4% YoY; but unprofitable (net margin -52.0%).
IDEAYA Biosciences, Inc. shows $219M in FY2025 revenue (+3024.4% YoY), a -52.0% net margin, and -11.1% ROE.
Sources: SEC EDGAR (CIK 0001676725, latest 10-Q filed 2026-05-05) · EODHD · as of 6/24/2026, 5:23:31 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.